Eppendorf Continues on Course for Success
News Aug 19, 2016
During the first half of the year, the Eppendorf Group recorded Group sales of €305.5 million (prior-year period: €289.6 million). The company’s sales growth of 5.5% (7.1% when adjusted for currency effects) put it above average market growth during the first half of the year. Income from operations (EBIT) climbed 23.3%, including strong positive currency effects, to €58.0 million (prior-year period: €47 million).
This positive result can be attributed, among other things, to good business development in China, where the market grew strongly during the first six months of the year. In addition, Eppendorf grew across all product groups just as it did in fiscal year 2015, and was able to profit from the market’s positive development.
Thomas Bachmann, Chief Executive Officer of Eppendorf AG, is optimistic about fiscal year 2016, adding, “We are especially pleased at our results in the field of bioprocessing, where we are positioning ourselves ever more strongly in the market. Our investments in service are paying off, too, and we can point to good growth rates here as well. I assume we will once again achieve growth for the entire fiscal year 2016 that exceeds the projected current industry average of 4%.”
Grafted Brain Organoids Provide Insight into Neurological DisordersNews
Salk scientists improve the growth of three-dimensional brain models to better understand autism, dementia, schizophrenia.READ MORE
New Process to Differentiate Stem Cells into Nucleus Pulposus-Like CellsNews
Researchers at Washington University have developed a new way to transform human induced pluripotent stem cells into nucleus pulposus cells, which are the chief component of intervertebral discs.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018